Compare ARK Genomic Revolution ETF (ARKG) vs Direxion Daily FTSE China Bull 3x Shares (YINN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Direxion Daily FTSE China Bull 3x Shares — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Direxion Daily FTSE China Bull 3x Shares trades at $25.35. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Direxion Daily FTSE China Bull 3x Shares nearer its low. Which is the better fit depends on your goals.
| ARKG | YINN | |
|---|---|---|
Sector | Sector/Thematic | Leveraged / Inverse |
52-Week High | $43.57 | $56.62 |
52-Week Low | $23.09 | $21.45 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
YINN trades at $25.36, up 0.6% with a bullish technical signal despite mixed indicators. The ETF shows neutral oscillators but bearish moving averages, with key resistance at $26. Recent news highlights China's AI investment push and improved macro sentiment, though geopolitical tensions with the U.S. persist. The fund's leveraged structure amplifies both gains and risks in Chinese equities.
Outlook remains cautious due to YINN's 3x leverage amplifying volatility. Opportunities exist from China's $295 billion AI infrastructure plan and strong export growth, but risks include U.S.-China tech rivalry, regulatory scrutiny, and value trap concerns. Investors should weigh leveraged exposure against fundamental headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Direxion Daily FTSE China Bull 3x Shares
YINN is a leveraged ETF that seeks daily investment results, before fees and expenses, of 300% (3x) of the daily performance of the FTSE China 50 Index. It is a tactical instrument designed for sophisticated traders seeking to magnify short-term bullish views on large-cap Chinese equities, primarily those trading on the Hong Kong Stock Exchange.
Read more on YINN →
